🇺🇸 FDA
Pipeline program

HEC53856

HEC53856-RAD-102

Phase 1 small_molecule completed

Quick answer

HEC53856 for Chronic Kidney Diseases is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Chronic Kidney Diseases
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials